Hedge funds run by legendary names like Nelson Peltz and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors (you’ve got to have a minimum of $1 million liquid to invest in a hedge fund) by spending enormous resources on analyzing and uncovering data about small-cap stocks that the big brokerage houses don’t follow. Small caps are where they can generate significant out-performance. That’s why we pay special attention to hedge fund activity in these stocks.
Is Assembly Biosciences Inc (NASDAQ:ASMB) worth your attention right now? Money managers are becoming less confident. The number of bullish hedge fund positions decreased by 2 recently. At the end of this article we will also compare ASMB to other stocks, including Allot Communications Ltd. (NASDAQ:ALLT), Emerge Energy Services LP (NYSE:EMES), and Orion Marine Group, Inc. (NYSE:ORN) to get a better sense of its popularity.
Follow Assembly Biosciences Inc. (NASDAQ:ASMB)
Follow Assembly Biosciences Inc. (NASDAQ:ASMB)
To most shareholders, hedge funds are perceived as underperforming, old investment vehicles of the past. While there are more than 8000 funds in operation at the moment, We choose to focus on the crème de la crème of this group, about 700 funds. These hedge fund managers manage the lion’s share of the hedge fund industry’s total asset base, and by tracking their first-class equity investments, Insider Monkey has unsheathed various investment strategies that have historically outstripped Mr. Market. Insider Monkey’s small-cap hedge fund strategy exceeded the S&P 500 index by 12 percentage points annually for a decade in their back tests.
With all of this in mind, we’re going to take a gander at the new action regarding Assembly Biosciences Inc (NASDAQ:ASMB).
How have hedgies been trading Assembly Biosciences Inc (NASDAQ:ASMB)?
Heading into Q4, a total of 12 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of -14% from one quarter earlier. With the smart money’s sentiment swirling, there exists a few notable hedge fund managers who were boosting their stakes substantially (or already accumulated large positions).
According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Oleg Nodelman’s EcoR1 Capital has the largest position in Assembly Biosciences Inc (NASDAQ:ASMB), worth close to $18 million, amounting to 8.2% of its total 13F portfolio. Coming in second is Visium Asset Management, managed by Jacob Gottlieb, which holds a $15.3 million position; 0.2% of its 13F portfolio is allocated to the company. Some other members of the smart money that hold long positions consist of Samuel Isaly’s OrbiMed Advisors, Joseph Edelman’s Perceptive Advisors and Daniel Gold’s QVT Financial.